Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
JCI Insight
|
October 24, 2022
NOX4 inhibition promotes the remodeling of dystrophic muscle
David W Hammers
Circulation. Heart Failure
|
March 30, 2019
RevAMP(K)ing Mitochondria for Sarcoglycanopathy Therapeutics
David W Hammers
Cold Spring Harbor Perspectives in Biology
|
February 9, 2018
Muscle Contraction
H Lee Sweeney, David W Hammers
Plos One
|
November 22, 2016
Activin Receptor Type IIB Inhibition Improves Muscle Phenotype and Function in a Mouse Model of Spinal Muscular Atrophy
Min Liu, David W Hammers, Elisabeth R Barton, et al.
BMC Cardiovascular Disorders
|
April 11, 2025
Effect of Tadalafil on cardiac function and left ventricular dimensions in Duchenne muscular dystrophy: safety and cardiac MRI substudy results from a randomized, placebo-controlled trial
David Cox, Barry Byrne, David W Hammers, et al.
Journal of Molecular and Cellular Cardiology Plus
|
May 19, 2023
Evaluation of the DBA/2J mouse as a potential background strain for genetic models of cardiomyopathy
Cora C Hart, Young Il Lee, David W Hammers, et al.
Muscle & Nerve
|
December 1, 2015
Increased collagen cross-linking is a signature of dystrophin-deficient muscle
Lucas R Smith, David W Hammers, H Lee Sweeney, et al.
Biorxiv : the Preprint Server for Biology
|
September 2, 2025
Dual S100A1 and ARC gene therapy as a treatment for DMD cardiomyopathy
David W Hammers, Cora C Hart, Young Il Lee, et al.
American Journal of Translational Research
|
April 12, 2019
Smooth muscle atrophy and colon pathology in SMN deficient mice
Yun Yang, George Vassilakos, David W Hammers, et al.
Biotechnology and Bioengineering
|
November 19, 2011
Controlled release of IGF-I from a biodegradable matrix improves functional recovery of skeletal muscle from ischemia/reperfusion
David W Hammers, Apurva Sarathy, Chantal B Pham, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
JCI Insight
|
October 24, 2022
NOX4 inhibition promotes the remodeling of dystrophic muscle
David W Hammers
Circulation. Heart Failure
|
March 30, 2019
RevAMP(K)ing Mitochondria for Sarcoglycanopathy Therapeutics
David W Hammers
Cold Spring Harbor Perspectives in Biology
|
February 9, 2018
Muscle Contraction
H Lee Sweeney, David W Hammers
Plos One
|
November 22, 2016
Activin Receptor Type IIB Inhibition Improves Muscle Phenotype and Function in a Mouse Model of Spinal Muscular Atrophy
Min Liu, David W Hammers, Elisabeth R Barton, et al.
BMC Cardiovascular Disorders
|
April 11, 2025
Effect of Tadalafil on cardiac function and left ventricular dimensions in Duchenne muscular dystrophy: safety and cardiac MRI substudy results from a randomized, placebo-controlled trial
David Cox, Barry Byrne, David W Hammers, et al.
Journal of Molecular and Cellular Cardiology Plus
|
May 19, 2023
Evaluation of the DBA/2J mouse as a potential background strain for genetic models of cardiomyopathy
Cora C Hart, Young Il Lee, David W Hammers, et al.
Muscle & Nerve
|
December 1, 2015
Increased collagen cross-linking is a signature of dystrophin-deficient muscle
Lucas R Smith, David W Hammers, H Lee Sweeney, et al.
Biorxiv : the Preprint Server for Biology
|
September 2, 2025
Dual S100A1 and ARC gene therapy as a treatment for DMD cardiomyopathy
David W Hammers, Cora C Hart, Young Il Lee, et al.
American Journal of Translational Research
|
April 12, 2019
Smooth muscle atrophy and colon pathology in SMN deficient mice
Yun Yang, George Vassilakos, David W Hammers, et al.
Biotechnology and Bioengineering
|
November 19, 2011
Controlled release of IGF-I from a biodegradable matrix improves functional recovery of skeletal muscle from ischemia/reperfusion
David W Hammers, Apurva Sarathy, Chantal B Pham, et al.
Page
of 4